R&D

In response to questions from Science|Business, US and EU officials sent this statement about a research-planning meeting they held October 12 in Brussels

Amidst the political chaos in London, the UK’s official statistics office set off a small storm by raising its estimate of how much UK companies invest in R&D. The odd episode highlights how important R&D statistics have become politically

With weeks to go before the Commission publishes its legislative proposals, members of the parliament’s ITRE committee are divided over how to secure the future of Europe’s most research intensive sector

New “spin-in” calls are part of a broader effort to ensure civilian technologies developed under Horizon Europe can be taken up and applied by European Defence Fund projects

There is broad support for EU Chips Act’s ambition of reducing reliance on imports of semiconductors, but experts are questioning the means and goals

Recent US legislation includes significant tax credits for nuclear energy. Along with other federal investments, this could reinvigorate the industry and stimulate cross-Atlantic R&D

Development of vaccines and therapeutics is highly risky and takes time. New models are needed to ensure we are prepared for fresh outbreaks of disease and emerging infections

Poor funding, short-term thinking and staff problems are hindering American collaboration in global science, says report to Congress. But it’s unclear what will be done about it

After being sent back to the drawing board last year, the budget for the partnership has been cut from a proposed €1.4B - €2B to a miserly €150M. Despite a parallel reduction in its scope, companies say they will struggle to deliver

The funding is part of a $90 billion programme to set up demonstrators, with the aim of accelerating deployment of new types of energy at scale